1. Home
  2. TCRT vs SYNX Comparison

TCRT vs SYNX Comparison

Compare TCRT & SYNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Alaunos Therapeutics Inc.

TCRT

Alaunos Therapeutics Inc.

HOLD

Current Price

$3.23

Market Cap

7.7M

Sector

Health Care

ML Signal

HOLD

Logo Silynxcom Ltd.

SYNX

Silynxcom Ltd.

HOLD

Current Price

$1.12

Market Cap

7.1M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
TCRT
SYNX
Founded
1998
2005
Country
United States
Israel
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.7M
7.1M
IPO Year
2025
2023

Fundamental Metrics

Financial Performance
Metric
TCRT
SYNX
Price
$3.23
$1.12
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
11.6K
3.3M
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$15,900,000.00
N/A
Revenue This Year
$5,680,500.00
$32.35
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.31
$0.73
52 Week High
$5.48
$4.55

Technical Indicators

Market Signals
Indicator
TCRT
SYNX
Relative Strength Index (RSI) 53.70 50.20
Support Level $2.89 $0.90
Resistance Level $3.73 $1.31
Average True Range (ATR) 0.25 0.17
MACD 0.01 0.01
Stochastic Oscillator 55.24 19.23

Price Performance

Historical Comparison
TCRT
SYNX

About TCRT Alaunos Therapeutics Inc.

Alaunos Therapeutics Inc is a preclinical stage obesity and metabolic health drug development company that is aiming to develop a small molecule-based drug to treat obesity and other metabolic disorders that have a differentiated profile relative to currently marketed and in development oral and injectable products. The company focuses on evaluating the impact of ALN1001, its primary program, and its derivatives on lipid deposition and gene expression. It aims to develop an oral obesity compound that addresses many of the shortcomings of injectable GLP-1 receptor agonists including preserving lean muscle mass.

About SYNX Silynxcom Ltd.

Silynxcom Ltd is engaged in developing, manufacturing, marketing, and selling ruggedized Personal Headset Devices as well as other communications accessories, all of which have been battlefield-tested and combat proved. It specializes in developing the In-Ear Headset device, a subsegment of the Personal Headset Device market. The In-Ear Headset device is used in both training and operations by the military, law enforcement, and disaster recovery industry professionals. It also develops, markets, and sell push-to-talk devices, communication controllers, and communication device cables and connectors.

Share on Social Networks: